CIBC Private Wealth Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

CIBC Private Wealth Group’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$420	Hold	1,000	–	–	﹤0.01%	3075
2025 Q3	$673	Hold	1,000	–	–	﹤0.01%	2864
2025 Q2	$541	Hold	1,000	–	–	﹤0.01%	2829
2025 Q1	$628	Hold	1,000	–	–	﹤0.01%	2872
2024 Q4	$1.22K	Hold	1,000	–	–	﹤0.01%	2768
2024 Q3	$866	Hold	1,000	–	–	﹤0.01%	2925
2024 Q2	$318	Hold	1,000	–	–	﹤0.01%	3015
2024 Q1	$608	Buy	+1,000	New	+$725	﹤0.01%	2915
2018 Q3	–	Sell	-1,000	Closed	-$14K	–	1585
2018 Q2	$14K	Sell	1,000 -395	-28%	-$6.56K	﹤0.01%	1492
2018 Q1	$27K	Buy	1,395 +395	+40%	+$8.44K	﹤0.01%	1310
2017 Q4	$16K	Buy	+1,000	New	+$14.9K	﹤0.01%	1449

Other funds holding SGMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CIBC Private Wealth Group's SGMO Position: Q4 2025 in Review

CIBC Private Wealth Group held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q4 2025 at 1,000 shares worth $420. The position accounts for ﹤0.01% of the portfolio, ranked #3075.

CIBC Private Wealth Group first reported a position in SGMO in Q4 2017 and has held it in 11 quarters since. The position peaked at $27K in Q1 2018. 105 funds tracked by Wall St. Rank hold SGMO as of Q4 2025.

CIBC Private Wealth Group held 1,000 shares of SANGAMO THERAPEUTICS INC worth $420 as of Q4 2025.
CIBC Private Wealth Group left its SANGAMO THERAPEUTICS INC share count unchanged in Q4 2025.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3075 holding.
CIBC Private Wealth Group first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and has held it in 11 quarters since.
CIBC Private Wealth Group's SANGAMO THERAPEUTICS INC position peaked at $27K in Q1 2018.
105 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.